Correlation Between Effector Therapeutics and Palisade Bio
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Palisade Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Palisade Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Palisade Bio, you can compare the effects of market volatilities on Effector Therapeutics and Palisade Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Palisade Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Palisade Bio.
Diversification Opportunities for Effector Therapeutics and Palisade Bio
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Effector and Palisade is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Palisade Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palisade Bio and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Palisade Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palisade Bio has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Palisade Bio go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Palisade Bio
If you would invest 13.00 in Effector Therapeutics on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Effector Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Effector Therapeutics vs. Palisade Bio
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Palisade Bio |
Effector Therapeutics and Palisade Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Palisade Bio
The main advantage of trading using opposite Effector Therapeutics and Palisade Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Palisade Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will offset losses from the drop in Palisade Bio's long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |